POSB132 Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients with Acute Heart Failure with Reduced Ejection Fraction: Events Avoided and Cost Savings from the Perspective of Healthcare Payers in the United States
Autor: | McEwan, P, Ponikowski, P, Rosano, G, Coats, AJS, Dorigotti, F, O'Sullivan, D, Ramirez de Arellano Serna, A, Jankowska, EA |
---|---|
Zdroj: | In Value in Health January 2022 25(1) Supplement:S86-S86 |
Databáze: | ScienceDirect |
Externí odkaz: |